Infinium Pharmachem bulk deals and insider trading
NSE: INFINIUMPharmaceuticals & Biotechnology
Share price at the NSE close on 30 Oct 2026. Previous close ₹278.00.
30 Oct: open ₹285.75, high ₹285.75, low ₹281.00
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹438 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.04
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.62
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,500100.0% delivered
Infinium Pharmachem's insiders have 7 trade disclosures on record, the latest on 21 Jul 2025. Its promoter group made no purchase or sale on the market in the 12 months to 30 Oct 2026.
Infinium Pharmachem insider trading
The company's own latest disclosure on record is from Jul 2025.Insider trading, all companies
Jul 2025
- Pravin Bhadabhai Madhani14,72,720sharesReceived · Promoters · 21 Jul 2025 · Gift · stake 12.20% before, 21.65% after
- Bhadabhai Kacharabhai Madhani14,72,720sharesGave · Promoter Group · 21 Jul 2025 · Gift · held 14,72,720 before
- Varshaben Pravinbhai Madhani7,79,156sharesGave · Promoter Group · 21 Jul 2025 · Gift · stake 7.35% before, 2.35% after
- Krunal Pravinbhai Madhani7,79,156sharesReceived · Promoter Group · 21 Jul 2025 · Gift · holds 7,79,156 after, stake 5.00% after
Jun 2025
- BHADABHAI KACHARABHAI MADHANI₹0.59 Cr20,000 sharesSold or invoked · Promoter · 4 Jun 2025 · disclosed 6 Jun
- BHARAT KHODABHAI MADHANI₹0.92 Cr31,000 sharesSold or invoked · Promoter · 3 Jun 2025 · disclosed 5 Jun
Jun 2024
- DIPAKKUMAR RAVAJIBHAI PRAJAPATI₹0.12 Cr5,500 sharesSold or invoked · Designated Person · 14 Jun 2024 · disclosed 20 Jun
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Infinium Pharmachem bulk deals
None in the last 12 months, since 1 Nov 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 18 Apr 20232 firms · ₹0 bought · ₹1.31 Cr soldNet sold ₹1.31 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 50,000 at ₹146.00₹0.73 Cr
- SoldRUSHABH BHARATBHAISold 38,000 at ₹153.34₹0.58 Cr
Monday 17 Apr 20236 firms · ₹4.16 Cr bought · ₹0.45 Cr soldNet bought ₹3.71 Cr
- BoughtPRAGNA HITESH LUNAGARIYABought 76,000 at ₹141.50₹1.08 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 50,000 at ₹141.50₹0.71 Cr
- BoughtBHUPESH VAHALABHAI PATELBought 45,000 at ₹141.50₹0.64 Cr
- BoughtSHRIPAL V VORA (HUF)Bought 36,000 at ₹148.45₹0.53 Cr
- BoughtDHARAMSHI GORDHANBHAI PATELBought 35,000 at ₹141.50₹0.50 Cr
- Both waysSWASTIKA INVESTMART LIMITEDBought 50,000 at ₹141.50Sold 30,000 at ₹148.55Net +20,000 shares₹0.71 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 9 deals on record since listing on 17 Apr 2023.